AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29659574 — intervention group
Group type: EXPERIMENTAL
Intervention: School WASH intervention
Number of subjects: 807
Study 29659574 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison schools)
Number of subjects: 807
Study 26812804 — intervention group
Group type: EXPERIMENTAL
Intervention: Active hypnotic drug
Number of subjects: 2
Study 26812804 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender effect
Number of subjects: 2
Study 24595916 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual arousal manipulation
Number of subjects: 0
Study 22352703 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lipid emulsion
Number of subjects: 8
Study 22352703 — intervention group
Group type: COMPARATOR
Intervention: Hartmann's solution
Number of subjects: 8
Study 20194315 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-subvastus approach
Number of subjects: 51
Study 20194315 — intervention group
Group type: COMPARATOR
Intervention: Mini-midvastus approach
Number of subjects: 51
Study 17095129 — intervention group
Group type: EXPERIMENTAL
Intervention: Menjugate vaccine stored at room temperature (25+/‐2 degrees C)
Number of subjects: 500
Study 17095129 — intervention group
Group type: COMPARATOR
Intervention: Menjugate vaccine stored at 2‐8 degrees C
Number of subjects: 500
Study 15735184 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 8722
Study 15735184 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 8722
Study 12217264 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive-message group
Number of subjects: 118
Study 12217264 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-message group
Number of subjects: 118
Study 12217264 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 118
Study 9690722 — intervention group
Group type: EXPERIMENTAL
Intervention: Rennie (calcium‐magnesium carbonate) 1360 mg
Number of subjects: 16
Study 9690722 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 75 mg
Number of subjects: 16
Study 9690722 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 10 mg
Number of subjects: 16
Study 9690722 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 8080392 — intervention group
Group type: COMPARATOR
Intervention: MMSE items (day, date, recall of apple, recall of penny)
Number of subjects: 1033
Study 8080392 — intervention group
Group type: COMPARATOR
Intervention: MMSE items (month, city, spelling world backward, county)
Number of subjects: 1033
Study 8080392 — intervention group
Group type: COMPARATOR
Intervention: MMSE items (floor of building, repeating the word table, naming watch, folding paper in half)
Number of subjects: 1033
Study 2607484 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonaggressive music and nonaggressive lyrics
Number of subjects: 90
Study 2607484 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive music and nonaggressive lyrics
Number of subjects: 90
Study 2607484 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive music and aggressive lyrics
Number of subjects: 90
Study 1235478 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional and hepatitis B immune serum globulin
Number of subjects: 0
Study 1235478 — intervention group
Group type: COMPARATOR
Intervention: Routine screening of donor blood by radioimmunoassay techniques
Number of subjects: 0
Study 1235478 — intervention group
Group type: COMPARATOR
Intervention: Commercial blood use
Number of subjects: 0
Study 30762416 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed about video recording
Number of subjects: 122
Study 30762416 — intervention group
Group type: COMPARATOR
Intervention: Not informed about video recording
Number of subjects: 122
Study 27977057 — intervention group
Group type: EXPERIMENTAL
Intervention: Otlertuzumab (20 mg/kg) weekly by IV infusion for two 28-day cycles then every 14 days for four 28-day cycles + IV bendamustine (70 mg/m2) on Days 1 and 2 of each cycle for up to six 28-day cycles
Number of subjects: 65
Study 27977057 — intervention group
Group type: COMPARATOR
Intervention: Bendamustine alone
Number of subjects: 65
Study 26041316 — intervention group
Group type: EXPERIMENTAL
Intervention: Large dose remifentanil (0.30 μg/kg/min) + low-dose naloxone (0.25 μg/kg/h)
Number of subjects: 72
Study 26041316 — intervention group
Group type: EXPERIMENTAL
Intervention: Small dose remifentanil (0.1 μg/kg/min)
Number of subjects: 72
Study 26041316 — intervention group
Group type: COMPARATOR
Intervention: Large dose remifentanil (0.30 μg/kg/min)
Number of subjects: 72
Study 23841967 — intervention group
Group type: EXPERIMENTAL
Intervention: Gesture Therapy (virtual reality rehabilitation)
Number of subjects: 8
Study 21501179 — intervention group
Group type: EXPERIMENTAL
Intervention: CFAE ablation plus ostial pulmonary vein isolation (PVI)
Number of subjects: 116
Study 21501179 — intervention group
Group type: COMPARATOR
Intervention: Circumferential PVI plus additional lines (linear ablation)
Number of subjects: 116
Study 21501179 — intervention group
Group type: EXPERIMENTAL
Intervention: CFAE ablation plus ostial PVI
Number of subjects: 116
Study 19675494 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week training regimen
Number of subjects: 58
Study 19675494 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific training program)
Number of subjects: 58
Study 17393625 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 57
Study 17393625 — intervention group
Group type: COMPARATOR
Intervention: Simple acupuncture
Number of subjects: 57
Study 15101612 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyburide
Number of subjects: 75
Study 11136169 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-dialysis-dependent renal insufficiency (NDDRI)
Number of subjects: 16989
Study 11136169 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis-dependent patients
Number of subjects: 16989
Study 11136169 — intervention group
Group type: COMPARATOR
Intervention: Reference group (creatinine < 2.3 mg/dL)
Number of subjects: 16989
Study 9264833 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy with Transfer factor for three months
Number of subjects: 10
Study 8123406 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.15% isoflurane in oxygen
Number of subjects: 24
Study 8123406 — intervention group
Group type: COMPARATOR
Intervention: 0.5% isoflurane with 70% nitrous oxide
Number of subjects: 24
Study 8123406 — intervention group
Group type: COMPARATOR
Intervention: Awake group (no intervention)
Number of subjects: 24
Study 3612828 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment format (communication skills followed by sexual skills)
Number of subjects: 11
Study 3612828 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic sex education (4 hours)
Number of subjects: 11
Study 29489709 — intervention group
Group type: EXPERIMENTAL
Intervention: Cleansing solution and dressing material used before insertion and after removal of SPC.
Number of subjects: 0
Study 29489709 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 27723550 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical technique with patent tract left at vaginal cuff for drainage (Group II)
Number of subjects: 568
Study 24142191 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicondylar total knee arthroplasty (TKA) for OA patients
Number of subjects: 128
Study 24142191 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicondylar total knee arthroplasty (TKA) for RA patients
Number of subjects: 128
Study 22368249 — intervention group
Group type: EXPERIMENTAL
Intervention: Gas chromatograph (GC) using a flame photometric detector
Number of subjects: 0
Study 22368249 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable gas chromatographs (GCs)
Number of subjects: 0
Study 22368249 — intervention group
Group type: EXPERIMENTAL
Intervention: ZnCl(2) products
Number of subjects: 0
Study 20851307 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFA supplementation (1.7 g daily for 3 months)
Number of subjects: 206
Study 20851307 — intervention group
Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 206
Study 17544566 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial reduction of the transtemporal insonation quality using a thin aluminium foil between the TCD probe and the skin.
Number of subjects: 46
Study 17544566 — intervention group
Group type: COMPARATOR
Intervention: Native insonation quality (no intervention).
Number of subjects: 46
Study 17544566 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrupted insonation quality (after intervention).
Number of subjects: 46
Study 21966763 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation (50 mg/day for six months)
Number of subjects: 20
Study 21966763 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation
Number of subjects: 20
Study 11779917 — intervention group
Group type: EXPERIMENTAL
Intervention: Angina class 1
Number of subjects: 3122
Study 11779917 — intervention group
Group type: EXPERIMENTAL
Intervention: Angina class 2
Number of subjects: 3122
Study 11779917 — intervention group
Group type: EXPERIMENTAL
Intervention: Angina class 3
Number of subjects: 3122
Study 11779917 — intervention group
Group type: COMPARATOR
Intervention: No angina
Number of subjects: 3122
Study 11779917 — intervention group
Group type: COMPARATOR
Intervention: Angina class 1 vs No angina
Number of subjects: 3122
Study 11779917 — intervention group
Group type: COMPARATOR
Intervention: Angina class 2 vs No angina
Number of subjects: 3122
Study 11779917 — intervention group
Group type: COMPARATOR
Intervention: Angina class 3 vs No angina
Number of subjects: 3122
Study 11779917 — intervention group
Group type: COMPARATOR
Intervention: Conventional risk factors
Number of subjects: 3122
Study 7715228 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent antegrade warm blood cardioplegia
Number of subjects: 30
Study 7715228 — intervention group
Group type: COMPARATOR
Intervention: Intermittent antegrade cold blood cardioplegia
Number of subjects: 30
Study 2766869 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course ceftriaxone therapy (4, 6, and 7 days depending on the pathogen)
Number of subjects: 52
Study 2766869 — intervention group
Group type: COMPARATOR
Intervention: Standard-length ceftriaxone therapy (twice as long as short-course)
Number of subjects: 52
Study 800972 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of muzolimine (80 mg) and spironolactone (300 mg)
Number of subjects: 22
Study 800972 — intervention group
Group type: COMPARATOR
Intervention: Combination of furosemide (80 mg) and spironolactone (300 mg)
Number of subjects: 22
Study 800972 — intervention group
Group type: COMPARATOR
Intervention: Placebo and spironolactone (300 mg)
Number of subjects: 22
Study 31196734 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-FIT
Number of subjects: 9787
Study 31196734 — intervention group
Group type: COMPARATOR
Intervention: 2-FIT
Number of subjects: 9787
Study 27613880 — intervention group
Group type: EXPERIMENTAL
Intervention: Active first generation ECs
Number of subjects: 24
Study 27613880 — intervention group
Group type: COMPARATOR
Intervention: Placebo ECs
Number of subjects: 24
Study 27613880 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturalistic smoking week
Number of subjects: 24
Study 27613880 — intervention group
Group type: EXPERIMENTAL
Intervention: Active EC week
Number of subjects: 24
Study 27613880 — intervention group
Group type: COMPARATOR
Intervention: Placebo EC week
Number of subjects: 24
Study 26788786 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI ≥30.0 kg/m² (obese)
Number of subjects: 2276
Study 26788786 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI 25.0-29.9 kg/m² (overweight)
Number of subjects: 2276
Study 26788786 — intervention group
Group type: EXPERIMENTAL
Intervention: WHR 0.80-0.84
Number of subjects: 2276
Study 26788786 — intervention group
Group type: EXPERIMENTAL
Intervention: WHR ≥0.85
Number of subjects: 2276
Study 26788786 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated WHR and higher BMI
Number of subjects: 2276
Study 23539903 — intervention group
Group type: EXPERIMENTAL
Intervention: Ommaya reservoir treatment
Number of subjects: 60
Study 23539903 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment methods
Number of subjects: 60
Study 21337032 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubeless PNL (double-J ureteral stent)
Number of subjects: 85
Study 21337032 — intervention group
Group type: COMPARATOR
Intervention: Conventional PNL (nephrostomy tube)
Number of subjects: 85
Study 21337032 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubeless PNL
Number of subjects: 85
Study 21337032 — intervention group
Group type: COMPARATOR
Intervention: Conventional PNL
Number of subjects: 85
Study 19800704 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel SIB strategy with prescribed mean doses of 46.8 Gy to PTV(risk), 50.6 Gy to PTV(pre_chemo), and 58.1 Gy to PTV(post_chemo) in 25 fractions.
Number of subjects: 10
Study 19800704 — intervention group
Group type: COMPARATOR
Intervention: Conventional two-volume SIB plan (ignoring PTV(post_chemo)).
Number of subjects: 10
Study 17074942 — intervention group
Group type: EXPERIMENTAL
Intervention: First acute treatment step
Number of subjects: 3794
Study 17074942 — intervention group
Group type: EXPERIMENTAL
Intervention: Second acute treatment step
Number of subjects: 3794
Study 17074942 — intervention group
Group type: EXPERIMENTAL
Intervention: Third acute treatment step
Number of subjects: 3794
Study 17074942 — intervention group
Group type: EXPERIMENTAL
Intervention: Fourth acute treatment step
Number of subjects: 3794
Study 17074942 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cumulative remission rate
Number of subjects: 3794
Study 17074942 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturalistic follow-up phase
Number of subjects: 3794
Study 15556256 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% soluble guar gum (fiber-enriched diet)
Number of subjects: 20
Study 15556256 — intervention group
Group type: COMPARATOR
Intervention: Fiber-free diet (control group)
Number of subjects: 20
Study 11771024 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline 50 mg/day for the first week and 100 mg/day for the following 5 weeks
Number of subjects: 37
Study 11771024 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose starch tablets, 1 tablet/day for 6 weeks)
Number of subjects: 37
Study 9670288 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutron therapy
Number of subjects: 100
Study 9670288 — intervention group
Group type: COMPARATOR
Intervention: Photon therapy
Number of subjects: 100
Study 7508219 — intervention group
Group type: COMPARATOR
Intervention: LPS group (NSR plus 200 micrograms/kg of lipopolysaccharide)
Number of subjects: 24
Study 7508219 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS/NAME group (NSR, LPS, and continuous infusion of 50 micrograms/kg per minute of N‐nitro‐L‐arginine methyl ester)
Number of subjects: 24
Study 7508219 — intervention group
Group type: EXPERIMENTAL
Intervention: NAME group (NSR and NAME)
Number of subjects: 24
Study 7508219 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal saline resuscitation)
Number of subjects: 24
Study 3169167 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-step stimuli with ISI of 25 or 50 ms
Number of subjects: 0
Study 3169167 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-step stimuli with ISI of 75 or 100 ms
Number of subjects: 0
Study 29660572 — intervention group
Group type: EXPERIMENTAL
Intervention: Incorrigibility in D+ group at baseline
Number of subjects: 79
Study 29660572 — intervention group
Group type: EXPERIMENTAL
Intervention: Delusion severity in D+ group
Number of subjects: 79
Study 29660572 — intervention group
Group type: EXPERIMENTAL
Intervention: Jumping-to-conclusions (JTC) in D+ and D- groups
Number of subjects: 79
Study 28879820 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Start intervention
Number of subjects: 285
Study 27017701 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoflavin (10 mL in 200 mL of 0.9% sodium chloride for 10 days, then 2 tablets twice a day for 25 days)
Number of subjects: 60
Study 27017701 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment with oral antidiabetic drugs (metformin monotherapy or combined therapy)
Number of subjects: 60
Study 27017701 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoflavin
Number of subjects: 60
Study 27017701 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cytoflavin)
Number of subjects: 60
Study 27017701 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 23170993 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy dog visits (average duration 12 minutes)
Number of subjects: 155
Study 23170993 — intervention group
Group type: COMPARATOR
Intervention: Waiting room control (average duration 17 minutes)
Number of subjects: 155
Study 21224421 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum feeding
Number of subjects: 9
Study 19481565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclopean motion using a random-dot binocular correlogram with a moving square-wave grating defined by binocular correlations
Number of subjects: 0
Study 19481565 — intervention group
Group type: COMPARATOR
Intervention: First-order motion (not explicitly defined in the abstract)
Number of subjects: 0
Study 16551897 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane at 0.5 MAC
Number of subjects: 20
Study 16551897 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1.0 MAC
Number of subjects: 20
Study 16551897 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane at 1.5 MAC
Number of subjects: 20
Study 12918026 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal-on-metal stable prosthesis (Group A) short-term (subgroup A(1))
Number of subjects: 15
Study 12918026 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal-on-metal stable prosthesis (Group A) medium-term (subgroup A(2))
Number of subjects: 15
Study 12918026 — intervention group
Group type: COMPARATOR
Intervention: Presurgical patients (Group B)
Number of subjects: 15
Study 12918026 — intervention group
Group type: COMPARATOR
Intervention: Reference values (Group C)
Number of subjects: 15
Study 11010607 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin sodium
Number of subjects: 3171
Study 11010607 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 3171
Study 9064235 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan containing dentifrice
Number of subjects: 0
Study 9064235 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 0
Study 9064235 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects instructed not to brush before evaluation
Number of subjects: 0
Study 7878632 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (6 g daily)
Number of subjects: 20
Study 7878632 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (placebo)
Number of subjects: 20
Study 2466855 — intervention group
Group type: EXPERIMENTAL
Intervention: Red krypton laser photocoagulation
Number of subjects: 0
Study 31152334 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy for insomnia (CBT-I)
Number of subjects: 151
Study 30140093 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified BFM regimen
Number of subjects: 0
Study 30140093 — intervention group
Group type: COMPARATOR
Intervention: BFM 90 protocol
Number of subjects: 0
Study 27568006 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant massage therapy administered by the mother until term equivalent age (TEA)
Number of subjects: 60
Study 27568006 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 60
Study 27568006 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant massage therapy
Number of subjects: 60
Study 25614529 — intervention group
Group type: EXPERIMENTAL
Intervention: Care of a Betta splendens pet fish
Number of subjects: 28
Study 25614529 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study 25614529 — intervention group
Group type: EXPERIMENTAL
Intervention: Care of a Betta splendens pet fish (younger adolescents 10-13 years)
Number of subjects: 28
Study 23942774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg + gp100 vaccine
Number of subjects: 676
Study 23942774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab 3 mg/kg + placebo
Number of subjects: 676
Study 23942774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab (all groups)
Number of subjects: 676
Study 23942774 — intervention group
Group type: COMPARATOR
Intervention: gp100 vaccine alone
Number of subjects: 676
Study 21351636 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (stage theory of organizational change)
Number of subjects: 479
Study 21351636 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 479
Study 18400731 — intervention group
Group type: EXPERIMENTAL
Intervention: Red grape juice (RGJ)
Number of subjects: 32
Study 18400731 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E
Number of subjects: 32
Study 18400731 — intervention group
Group type: EXPERIMENTAL
Intervention: Red grape juice (RGJ) + Vitamin E
Number of subjects: 32
Study 18400731 — intervention group
Group type: COMPARATOR
Intervention: Control (no supplementation)
Number of subjects: 32
Study 17345838 — intervention group
Group type: EXPERIMENTAL
Intervention: cetirizine 10mg
Number of subjects: 42
Study 17345838 — intervention group
Group type: EXPERIMENTAL
Intervention: desloratadine 5mg
Number of subjects: 42
Study 17345838 — intervention group
Group type: EXPERIMENTAL
Intervention: fexofenadine 120mg
Number of subjects: 42
Study 17345838 — intervention group
Group type: EXPERIMENTAL
Intervention: fexofenadine 180mg
Number of subjects: 42
Study 17345838 — intervention group
Group type: EXPERIMENTAL
Intervention: levocetirizine 5mg
Number of subjects: 42
Study 17345838 — intervention group
Group type: EXPERIMENTAL
Intervention: loratadine 10mg
Number of subjects: 42
Study 17345838 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 42
Study 12707129 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 2 micro g/kg
Number of subjects: 105
Study 12707129 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 3 micro g/kg
Number of subjects: 105
Study 12707129 — intervention group
Group type: EXPERIMENTAL
Intervention: remifentanil 4 micro g/kg
Number of subjects: 105
Study 10972634 — intervention group
Group type: EXPERIMENTAL
Intervention: Naratriptan (2.5 mg)
Number of subjects: 253